long intergenic non-protein coding RNA 2761Genealiases: []
Q-omics provides the consensus-scored LINC02761 profile across patient tissues and cancer cell-line models. LINC02761 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, LINC02761 is differentially expressed in 11, with the highest sampling consensus in KIRC. Additionally, LINC02761 RNA expression shows 15,308 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight UVM, KIRC, and ACC as cancer lineages where LINC02761 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02761 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02761 survival associations across molecular data types. LINC02761 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02761 RNA expression–survival associations across cancer types. High LINC02761 expression shows unfavorable associations in SKCM and KIRC, but favorable associations in UVM, KIRP, LGG and UCEC. The UVM Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for LINC02761 RNA expression.
This table summarizes LINC02761 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02761. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02761 shows lower tumor expression in KIRC, THCA, COAD, LUAD and BRCA and higher tumor expression in KICH. The KIRC box plot shows higher LINC02761 RNA expression in normal versus tumor tissue (log2 FC = −0.561, t-test p < 0.001).
This table shows molecular features associated with LINC02761 in patient tissues and cancer cell lines. In patient samples, LINC02761 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
